Literature DB >> 19034612

Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome.

Tohru Inaba1, Hiroshi Nishimura2, Junko Saito2, Yoko Yamane2, Takuya Nakatani3, Mio Yamamoto4, Hitoji Uchiyama4, Naohisa Fujita5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19034612     DOI： 10.1007/s12185-008-0204-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei).

Authors:  Weina Chen; Georgios Z Rassidakis; Jiang Li; Mark Routbort; Daniel Jones; Hagop Kantarjian; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Blood       Date:  2006-09-01       Impact factor: 22.113

2.  Acute myeloid leukemia-cuplike: characteristic peroxidase staining pattern.

Authors:  Akira Okano; Tohru Inaba
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

3.  HLA-DR antigen-negative acute myeloid leukemia.

Authors:  M Wetzler; B K McElwain; C C Stewart; L Blumenson; A Mortazavi; L A Ford; J L Slack; M Barcos; S Ferrone; M R Baer
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

4.  Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience.

Authors:  E Paietta; J Racevskis; J M Bennett; D Neuberg; P A Cassileth; J M Rowe; P H Wiernik
Journal:  Leukemia       Date:  1998-12       Impact factor: 11.528

5.  A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication.

Authors:  S J Kussick; D L Stirewalt; H S Yi; K M Sheets; E Pogosova-Agadjanyan; S Braswell; T H Norwood; J P Radich; B L Wood
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528

6.  Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.

Authors:  Chad P Soupir; Jo-Anne Vergilio; Paola Dal Cin; Alona Muzikansky; Hagop Kantarjian; Dan Jones; Robert P Hasserjian
Journal:  Am J Clin Pathol       Date:  2007-04       Impact factor: 2.493

Review 7.  Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.

Authors:  Yi-Kong Keung; Michael Beaty; Bayard L Powell; Istvan Molnar; David Buss; Mark Pettenati
Journal:  Leuk Res       Date:  2004-06       Impact factor: 3.156

Review 8.  Flow cytometric immunophenotyping for hematologic neoplasms.

Authors:  Fiona E Craig; Kenneth A Foon
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

9.  HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.

Authors:  A A Scott; D R Head; K J Kopecky; F R Appelbaum; K S Theil; M R Grever; I M Chen; M H Whittaker; B B Griffith; J D Licht
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.